Impact of endostatin gene therapy on myeloid-derived suppressor cells from a metastatic renal cell carcinoma

• Published in: Experimental Oncology
• Date: 2018
• Main Authors: Chaves, K.C.B., Costa, E.M., Teixeira, L.F., Bellini, M.H.
• Format: Article
• Language: English
• Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2018
• Subjects: Original contributions
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/139248
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: Impact of endostatin gene therapy on myeloid-derived suppressor cells from a metastatic renal cell carcinoma / K.C.B. Chaves, E.M. Costa, L.F. Teixeira, M.H. Bellini // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 24–32. — Бібліогр.: 48 назв. — англ.

Aim: To evaluate the role of endostatin (ES) gene therapy on myeloid-derived suppressor cells (MDSC) in a metastatic model of renal cell carcinoma (RCC). Materials and Methods: Balb/C mice bearing orthotopic Renca tumors were treated with NIH/3T3LendSN or, as a control, with NIH/3T3-LXSN cells. At t...